Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
Section snippets
Acknowledgements
This work was supported by grants from the Swedish Medical Research Council (grants Nos. 12103 and 11560); Alzheimerfonden; Stiftelsen för Gamla Tjänarinnor; Tore Nilssons Fond; Norrbottens Läns Landsting; Svenska Läkaresällskapet and Åke Wibergs Stiftelse.
References (20)
- et al.
‘Mini-Mental State’ A practical method for grading the cognitive state of patients for the clinician
J. Psychiatr. Res.
(1975) - et al.
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific A(monocloncals: evidence that an initially deposited species is Aβ42(43)
Neuron
(1994) - et al.
Cerebrospinal protein tau is elevated in early Alzheimer's disease
Neurosci. Lett.
(1996) - American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th edn., American Psychiatric...
- et al.
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study
J. Neurol. Neurosurg. Psychiatry
(1998) - et al.
Prevalence and incidence of memory recall disturbances in a geographically defined general population. The Piteȧ Dementia Project
Neuroepidemiology
(1999) - et al.
Cerebrospinal fluid β-amyloid(1–42) in Alzheimer's disease: differences between early- and late-onset AD and stability during the course of disease
Arch. Neurol.
(1999) - et al.
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer's disease?
Mol. Chem. Neuropathol.
(1995) - et al.
A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques
Neurology
(1988) - et al.
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease
Neurology
(1997)
There are more references available in the full text version of this article.
Cited by (241)
Recent advances in electrochemical biosensors for the detection of Aβ42, a biomarker for Alzheimer disease diagnosis
2023, TrAC - Trends in Analytical ChemistryA survey on machine and statistical learning for longitudinal analysis of neuroimaging data in Alzheimer's disease
2020, Computer Methods and Programs in BiomedicineAD biomarker discovery in CSF and in alternative matrices
2019, Clinical BiochemistryLongitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
2019, Alzheimer's and Dementia
Copyright © 1999 Elsevier Science Ireland Ltd. All rights reserved.